MoneyWorks4Me

Mangalam Drugs & Organics informs about outcome of board meeting

10 Jun 2016 Evaluate

Mangalam Drugs & Organics has informed that the Board of Directors of the Company at its meeting held on June 10, 2016, has approved the allotment of balance 14,50,000 Equity Shares of Rs 10 each at a premium of Rs 55 per share pursuant to exercise of right for conversion of remaining 14,50,000 warrants into equity shares to the promoter group on preferential basis, upon the receipt of balance consideration amount on it.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..